openPR Logo
Press release

Robotic Radiotherapy Marketis on an Upward Growth Curve

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Robotic Radiotherapy Market- (Product (Radiotherapy System, Software, 3D Camera, Others), Technology (Linear Accelators, Steriotactic Radiation Therapy, Particle Therapy), Application (Prostate Cancer, Breast Cancer, Lung Cancer, Head and Neck Cancer, Colorectal Cancer, and Other Cancers.), End-User (Hospitals, Independent Radiotherapy Centres)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Robotic Radiotherapy Market is valued at US$ 1.2 Bn in 2023, and it is expected to reach US$ 2.9 Bn by 2031, with a CAGR of 12.0% during the forecast period of 2024-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2501

Robotic radiotherapy is a sophisticated technique utilized in the treatment of cancer, leveraging advanced robotic technologies to administer highly precise radiation doses. This approach allows for accurate targeting of tumors while minimizing exposure to surrounding healthy tissues, making it particularly valuable for treating malignancies located in anatomically challenging or sensitive regions.

The increasing global incidence of cancer is fueling demand for advanced therapeutic solutions, with robotic radiotherapy emerging as a preferred option due to its precision and effectiveness. The market for robotic radiotherapy is experiencing significant growth, supported by continuous technological advancements and a rising emphasis on targeted cancer treatments. These robotic systems improve treatment accuracy, enhance operational efficiency, and reduce overall radiation exposure and treatment durations.

List of Prominent Players in the Robotic Radiotherapy Market:
• Varian Medical Systems, Inc.
• Elekta
• Accuray Incorporated
• Viewray Technologies, Inc.
• Panacea Medical Technologies Pvt. Ltd.
• Iba Proton Therapy
• Mevion Medical Systems
• Hitachi, Ltd.
• Sumitomo Heavy Industries, Ltd.
• Protom International
• Optivus Proton Therapy, Inc.
• P-Cure.
• Provision Healthcare, Llc
• Standard Imaging, Inc.
• Brainlab Ag
• C-Rad
• Raysearch Laboratories.
• Dosisoft Sa.
• Mim Software, Inc.
• Sun Nuclear Corporation
• Scandidos Ab
• Vision Rt
• Civco Radiotherapy
• Lap Gmbh Laser Applikationen
• Mvision Ai
• Linatech, Inc.

Market Dynamics:
Drivers:
The robotic radiotherapy market is primarily propelled by technological advancements that have significantly enhanced treatment precision and operational efficiency. These systems facilitate highly targeted radiation delivery, minimizing collateral damage to surrounding healthy tissues and thereby improving clinical outcomes and reducing adverse side effects. This level of precision is appealing to both patients and healthcare providers.

Unlock Your GTM Strategy:
https://www.insightaceanalytic.com/customisation/2501

Challenges:
Despite its promising outlook, the robotic radiotherapy market faces several challenges. The high capital expenditure associated with purchasing and maintaining robotic systems presents a major financial barrier for many healthcare providers. Moreover, effective system utilization requires specialized training for medical personnel, which can limit adoption rates.

Regional Trends:
North America is expected to maintain a dominant position in the robotic radiotherapy market, supported by a high rate of system adoption, advanced healthcare infrastructure, and a growing prevalence of cancer. The region benefits from strong governmental initiatives aimed at expanding access to advanced cancer treatments, along with favorable reimbursement environments. Furthermore, North America is home to several leading industry players-including Varian Medical Systems, Accuray Incorporated, and Elekta AB-who continue to invest in product innovation and development. These companies play a pivotal role in sustaining the region's leadership through the consistent delivery of cutting-edge robotic radiotherapy technologies.

Recent Developments:
• In June 2023, Ray Research Laboratories launched Ray Station 12A, an advanced treatment radiation planning system.
• In May 2023, Vision RT received approval from the FDA to commercialize its SGRT product, Map RT, in the US.
• In February 2022, MIM Software formed a partnership with Genesis Care, one of the largest providers of cancer care services in Australia.

Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/2501

Segmentation of Robotic Radiotherapy Market-
By Product
• Radiotherapy Systems
• Softwares
• 3D Cameras (Surface Guided)
• Others
By Technology
• Linear Accelerators
o Conventional Linear Accelerators
o MRI - Linear Accelerators
• Stereotactic Radiation Therapy Systems
o Cyberknife
o Gamma Knife
• Particle Therapy
o Proton Beam Therapy
o Heavy Ion beam Therapy
By Application
• Prostate Cancer
• Breast Cancer
• Lung Cancer
• Head & Neck Cancer
• Colorectal Cancer
• Other Cancers
By End-user
• Hospitals
• Independent Radiotherapy Centers
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Get More Information :
https://www.insightaceanalytic.com/report/robotic-radiotherapy-market/2501

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG

Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Robotic Radiotherapy Marketis on an Upward Growth Curve here

News-ID: 4114028 • Views:

More Releases from Insightace Analytic Pvt Ltd.

Aspiration & Biopsy Needles Market Know the Scope and Trends
Aspiration & Biopsy Needles Market Know the Scope and Trends
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Aspiration & Biopsy Needles Market- (By Product (Biopsy Needle (Core Biopsy Needles, Vacuum-Assisted Biopsy Needles), Aspiration Needle), By Application (Tumor/Cancer Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Kidney Cancer, Bone & Bone Marrow Cancer, Other Cancers), Wound Applications, Other Applications), By Procedure (Image-Guided (Ultrasound-Guided Procedures, Stereotactic Procedures, CT-Guided Procedures, MRI -Guided Procedures, Other
Acinetobacter Pneumonia Therapeutics Market Revenue Report with Forecast to 2034
Acinetobacter Pneumonia Therapeutics Market Revenue Report with Forecast to 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Acinetobacter Pneumonia Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Cephalosporins, Carbapenems, Aminoglycosides, Polymyxins), By Route of Administration (Oral, Intravenous, Others), Region, Market Outlook And Industry Analysis 2034" The global Acinetobacter Pneumonia Therapeutics Market Size is valued at USD 646.05 Mn in 2024 and is predicted to reach USD 1101.68 Mn by the
Traditional Medicine Market Exclusive Trends Analysis with Forecast to 2034
Traditional Medicine Market Exclusive Trends Analysis with Forecast to 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Traditional Medicine Market - (By Product (Herbal Medicine, Ayurvedic Medicine, Unani Medicine, Alternative Medicine, Homeopathy Medicine, Others ), By Form (Capsules and Tablets, Powders and Granules, Liquid Extracts, Syrups, Creams and Ointment, Others ), By Disease Indication (Cardiac Disorders, Bone and Joint Disorders, Gynecological Disorders, Neurological and Mental Disorders, Digestive Disorders, Others), By Distribution Channel
Personalized Medicine Biomarkers Market Exclusive Report on the Latest Revenue and Future Scope
Personalized Medicine Biomarkers Market Exclusive Report on the Latest Revenue a …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Personalized Medicine Biomarkers Market Size, Share & Trends Analysis Report By Type (Genetic Biomarkers, Protein Biomarkers, Metabolite Biomarkers), By Application (Oncology, Neurology, Diabetes, Autoimmune Diseases, Cardiology, Others), By End User (Hospitals, Diagnostic Laboratories, Research Institutions)- Market Outlook And Industry Analysis 2031" The Global Personalized Medicine Biomarkers Market is valued at US$ 22.9 Bn in 2023, and

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For